CAP-话题@MedSci

#CAP#

167篇内容 | 3516人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1898035, encodeId=6c7c1898035fa, content=<a href='/topic/show?id=832c404308' target=_blank style='color:#2F92EE;'>#CAP#</a>, objectTitle=2019年帕金森病及相关疾病世界大会（IAPRD）：INGREZZA和Opicapone的全新数据, objectType=article, longId=168237, objectId=8d6316823eb0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8d6316823eb0, replyNumber=0, likeNumber=56, createdTime=2020-05-09, rootId=0, userName=smlt2008, userId=c39f145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8d6316823eb0, moduleTitle=2019年帕金森病及相关疾病世界大会（IAPRD）：INGREZZA和Opicapone的全新数据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8d6316823eb0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1898044, encodeId=20c7189804434, content=<a href='/topic/show?id=832c404308' target=_blank style='color:#2F92EE;'>#CAP#</a>, objectTitle=2020 CAP临床指南：乳腺癌雌激素和孕激素受体检测, objectType=article, longId=186833, objectId=b7c918683399, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b7c918683399, replyNumber=0, likeNumber=38, createdTime=2020-04-01, rootId=0, userName=smlt2008, userId=c39f145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b7c918683399, moduleTitle=2020 CAP临床指南：乳腺癌雌激素和孕激素受体检测, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b7c918683399)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1898037, encodeId=2727189803e40, content=<a href='/topic/show?id=832c404308' target=_blank style='color:#2F92EE;'>#CAP#</a>, objectTitle=Eur Respir J：非流感病毒所致成人社区获得性肺炎病情严重程度与预后——一项来自CAP-China中国肺炎研究网的前瞻性注册登记研究, objectType=article, longId=169042, objectId=c2c116904293, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c2c116904293, replyNumber=0, likeNumber=92, createdTime=2020-04-04, rootId=0, userName=smlt2008, userId=c39f145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c2c116904293, moduleTitle=Eur Respir J：非流感病毒所致成人社区获得性肺炎病情严重程度与预后——一项来自CAP-China中国肺炎研究网的前瞻性注册登记研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c2c116904293)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1898032, encodeId=019c189803237, content=<a href='/topic/show?id=832c404308' target=_blank style='color:#2F92EE;'>#CAP#</a>, objectTitle=结肠良性病变解析——帽状息肉病（cap polyposis）, objectType=article, longId=165221, objectId=ca2716522194, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ca2716522194, replyNumber=0, likeNumber=77, createdTime=2019-09-27, rootId=0, userName=smlt2008, userId=c39f145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ca2716522194, moduleTitle=结肠良性病变解析——帽状息肉病（cap polyposis）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ca2716522194)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1898025, encodeId=7051189802593, content=<a href='/topic/show?id=832c404308' target=_blank style='color:#2F92EE;'>#CAP#</a>, objectTitle=NEJM：Caplacizumab治疗获得性血栓性血小板减少性紫癜, objectType=article, longId=157831, objectId=e6d915e83128, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e6d915e83128, replyNumber=0, likeNumber=0, createdTime=2019-08-05, rootId=0, userName=smlt2008, userId=c39f145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e6d915e83128, moduleTitle=NEJM：Caplacizumab治疗获得性血栓性血小板减少性紫癜, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e6d915e83128)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1898038, encodeId=6225189803898, content=<a href='/topic/show?id=832c404308' target=_blank style='color:#2F92EE;'>#CAP#</a>, objectTitle=帕金森病的新型辅助治疗：FDA接受了Opicapone的新药申请（NDA）, objectType=article, longId=175277, objectId=eca41e5277bd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eca41e5277bd, replyNumber=0, likeNumber=0, createdTime=2020-02-19, rootId=0, userName=smlt2008, userId=c39f145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eca41e5277bd, moduleTitle=帕金森病的新型辅助治疗：FDA接受了Opicapone的新药申请（NDA）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eca41e5277bd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1898031, encodeId=e5a0189803188, content=<a href='/topic/show?id=832c404308' target=_blank style='color:#2F92EE;'>#CAP#</a>, objectTitle=Int J Periodontics Restorative Dent：与BMP-2结合的仿生CaP涂层的应用增强了氧化锆植入物的种植体周围骨生成, objectType=article, longId=165165, objectId=b9441651655a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b9441651655a, replyNumber=0, likeNumber=77, createdTime=2019-05-12, rootId=0, userName=smlt2008, userId=c39f145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b9441651655a, moduleTitle=Int J Periodontics Restorative Dent：与BMP-2结合的仿生CaP涂层的应用增强了氧化锆植入物的种植体周围骨生成, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b9441651655a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1898034, encodeId=992c1898034dd, content=<a href='/topic/show?id=832c404308' target=_blank style='color:#2F92EE;'>#CAP#</a>, objectTitle=AKT抑制剂capivasertib联合氟维司群显著改善HR+晚期乳腺癌无进展生存, objectType=article, longId=167942, objectId=55fd16e94251, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=55fd16e94251, replyNumber=0, likeNumber=52, createdTime=2020-01-03, rootId=0, userName=smlt2008, userId=c39f145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=55fd16e94251, moduleTitle=AKT抑制剂capivasertib联合氟维司群显著改善HR+晚期乳腺癌无进展生存, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=55fd16e94251)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1898040, encodeId=783c18980402a, content=<a href='/topic/show?id=832c404308' target=_blank style='color:#2F92EE;'>#CAP#</a>, objectTitle=Int J Periodontics Restorative Dent：BMP-2+仿生CaP涂层可增强氧化锆种植体的骨结合, objectType=article, longId=177548, objectId=3ddb1e754810, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3ddb1e754810, replyNumber=0, likeNumber=60, createdTime=2019-11-06, rootId=0, userName=smlt2008, userId=c39f145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3ddb1e754810, moduleTitle=Int J Periodontics Restorative Dent：BMP-2+仿生CaP涂层可增强氧化锆种植体的骨结合, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3ddb1e754810)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1898019, encodeId=bf83189801945, content=<a href='/topic/show?id=832c404308' target=_blank style='color:#2F92EE;'>#CAP#</a>, objectTitle=Implant Dent：CaP涂层和低强度激光治疗刺激早期骨形成并改善粗糙螺纹植体的骨整合, objectType=article, longId=150546, objectId=45e215054681, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=45e215054681, replyNumber=0, likeNumber=56, createdTime=2018-11-13, rootId=0, userName=smlt2008, userId=c39f145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=45e215054681, moduleTitle=Implant Dent：CaP涂层和低强度激光治疗刺激早期骨形成并改善粗糙螺纹植体的骨整合, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=45e215054681)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1898033, encodeId=d93a189803354, content=<a href='/topic/show?id=832c404308' target=_blank style='color:#2F92EE;'>#CAP#</a>, objectTitle=ASCO 2019：AKT抑制剂capivasertib联合氟维司群显著改善HR+HER2-晚期乳腺癌结局, objectType=article, longId=167886, objectId=0bbd16e88668, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0bbd16e88668, replyNumber=0, likeNumber=61, createdTime=2020-03-19, rootId=0, userName=smlt2008, userId=c39f145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0bbd16e88668, moduleTitle=ASCO 2019：AKT抑制剂capivasertib联合氟维司群显著改善HR+HER2-晚期乳腺癌结局, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0bbd16e88668)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1898036, encodeId=1f771898036b6, content=<a href='/topic/show?id=832c404308' target=_blank style='color:#2F92EE;'>#CAP#</a>, objectTitle=Adv Healthc Mater：氧化石墨烯 - 铜纳米复合材料涂层多孔CaP支架通过激活Hif-1α进行血管化骨再生, objectType=article, longId=168942, objectId=9b9916894258, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9b9916894258, replyNumber=0, likeNumber=64, createdTime=2020-02-04, rootId=0, userName=smlt2008, userId=c39f145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9b9916894258, moduleTitle=Adv Healthc Mater：氧化石墨烯 - 铜纳米复合材料涂层多孔CaP支架通过激活Hif-1α进行血管化骨再生, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9b9916894258)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1898028, encodeId=4e831898028e2, content=<a href='/topic/show?id=832c404308' target=_blank style='color:#2F92EE;'>#CAP#</a>, objectTitle=2019 CAP指南：乳腺癌人表皮生长因子受体2免疫组化定量分析, objectType=article, longId=159143, objectId=231c15914303, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=231c15914303, replyNumber=0, likeNumber=26, createdTime=2019-01-31, rootId=0, userName=smlt2008, userId=c39f145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=231c15914303, moduleTitle=2019 CAP指南：乳腺癌人表皮生长因子受体2免疫组化定量分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=231c15914303)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1898021, encodeId=ba8f189802141, content=<a href='/topic/show?id=832c404308' target=_blank style='color:#2F92EE;'>#CAP#</a>, objectTitle=J Gastroenterology：Glecaprevir联合Pibrentasvir治疗对既往直接抗病毒治疗失败的慢性丙型肝炎患者的实际疗效分析, objectType=article, longId=151478, objectId=14541514e895, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=14541514e895, replyNumber=0, likeNumber=117, createdTime=2019-01-29, rootId=0, userName=smlt2008, userId=c39f145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=14541514e895, moduleTitle=J Gastroenterology：Glecaprevir联合Pibrentasvir治疗对既往直接抗病毒治疗失败的慢性丙型肝炎患者的实际疗效分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=14541514e895)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1898030, encodeId=bb9b1898030b9, content=<a href='/topic/show?id=832c404308' target=_blank style='color:#2F92EE;'>#CAP#</a>, objectTitle=ACS Appl Mater Interfaces：自组装可注射纳米复合水凝胶与原位生成的CaP纳米粒子协调骨再生, objectType=article, longId=164877, objectId=c6801648e790, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c6801648e790, replyNumber=0, likeNumber=70, createdTime=2019-08-30, rootId=0, userName=smlt2008, userId=c39f145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c6801648e790, moduleTitle=ACS Appl Mater Interfaces：自组装可注射纳米复合水凝胶与原位生成的CaP纳米粒子协调骨再生, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c6801648e790)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1898029, encodeId=afba189802911, content=<a href='/topic/show?id=832c404308' target=_blank style='color:#2F92EE;'>#CAP#</a>, objectTitle=J Endod：一种全新根管内封药2-hydroxyisocaproic Acid的细胞毒性和基因毒性分析：一项体外研究, objectType=article, longId=164289, objectId=d8ca16428935, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d8ca16428935, replyNumber=0, likeNumber=59, createdTime=2019-10-24, rootId=0, userName=smlt2008, userId=c39f145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d8ca16428935, moduleTitle=J Endod：一种全新根管内封药2-hydroxyisocaproic Acid的细胞毒性和基因毒性分析：一项体外研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d8ca16428935)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1898026, encodeId=a1cc189802694, content=<a href='/topic/show?id=832c404308' target=_blank style='color:#2F92EE;'>#CAP#</a>, objectTitle=JCLA：CAPN10基因的SNP43 (G/A)多态性增加了脑小血管疾病认知障碍的风险？, objectType=article, longId=158386, objectId=d426158386b9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d426158386b9, replyNumber=0, likeNumber=73, createdTime=2019-08-20, rootId=0, userName=smlt2008, userId=c39f145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d426158386b9, moduleTitle=JCLA：CAPN10基因的SNP43 (G/A)多态性增加了脑小血管疾病认知障碍的风险？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d426158386b9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1898016, encodeId=eb7d1898016c9, content=<a href='/topic/show?id=832c404308' target=_blank style='color:#2F92EE;'>#CAP#</a>, objectTitle=JCO：Capmatinib联合Gefitinib治疗EGFR抑制失败的非小细胞肺癌患者, objectType=article, longId=147810, objectId=bbcb14e81092, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bbcb14e81092, replyNumber=0, likeNumber=77, createdTime=2018-09-18, rootId=0, userName=smlt2008, userId=c39f145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bbcb14e81092, moduleTitle=JCO：Capmatinib联合Gefitinib治疗EGFR抑制失败的非小细胞肺癌患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bbcb14e81092)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1898020, encodeId=049a18980205c, content=<a href='/topic/show?id=832c404308' target=_blank style='color:#2F92EE;'>#CAP#</a>, objectTitle=Medscape | 美国五大常见癌症治疗的第一医院有哪些？, objectType=article, longId=151160, objectId=a1d415116053, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a1d415116053, replyNumber=0, likeNumber=89, createdTime=2019-04-05, rootId=0, userName=smlt2008, userId=c39f145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a1d415116053, moduleTitle=Medscape | 美国五大常见癌症治疗的第一医院有哪些？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a1d415116053)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1898015, encodeId=6efd18980154d, content=<a href='/topic/show?id=832c404308' target=_blank style='color:#2F92EE;'>#CAP#</a>, objectTitle=2018 CAP临床实践指南：乳腺癌HER2检测, objectType=article, longId=141582, objectId=c29c14158268, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c29c14158268, replyNumber=0, likeNumber=38, createdTime=2019-03-08, rootId=0, userName=smlt2008, userId=c39f145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c29c14158268, moduleTitle=2018 CAP临床实践指南：乳腺癌HER2检测, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c29c14158268)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

CAP

2020-05-29

smlt2008 (审核中...)

前往app查看评论内容

#CAP#

2019年帕金森病及相关疾病世界大会（IAPRD）：INGREZZA和Opicapone的全新数据

2020-05-09

smlt2008 (审核中...)

前往app查看评论内容

#CAP#

2020 CAP临床指南：乳腺癌雌激素和孕激素受体检测

2020-04-01

smlt2008 (审核中...)

前往app查看评论内容

#CAP#

Eur Respir J：非流感病毒所致成人社区获得性肺炎病情严重程度与预后——一项来自CAP-China中国肺炎研究网的前瞻性注册登记研究

2020-04-04

smlt2008 (审核中...)

前往app查看评论内容

#CAP#

结肠良性病变解析——帽状息肉病（cap polyposis）

2019-09-27

smlt2008 (审核中...)

前往app查看评论内容

#CAP#

NEJM：Caplacizumab治疗获得性血栓性血小板减少性紫癜

2019-08-05

smlt2008 (审核中...)

前往app查看评论内容

#CAP#

帕金森病的新型辅助治疗：FDA接受了Opicapone的新药申请（NDA）

2020-02-19

smlt2008 (审核中...)

前往app查看评论内容

#CAP#

Int J Periodontics Restorative Dent：与BMP-2结合的仿生CaP涂层的应用增强了氧化锆植入物的种植体周围骨生成

2019-05-12

smlt2008 (审核中...)

前往app查看评论内容

#CAP#

AKT抑制剂capivasertib联合氟维司群显著改善HR+晚期乳腺癌无进展生存

2020-01-03

smlt2008 (审核中...)

前往app查看评论内容

#CAP#

Int J Periodontics Restorative Dent：BMP-2+仿生CaP涂层可增强氧化锆种植体的骨结合

2019-11-06

smlt2008 (审核中...)

前往app查看评论内容

#CAP#

Implant Dent：CaP涂层和低强度激光治疗刺激早期骨形成并改善粗糙螺纹植体的骨整合

2018-11-13

smlt2008 (审核中...)

前往app查看评论内容

#CAP#

ASCO 2019：AKT抑制剂capivasertib联合氟维司群显著改善HR+HER2-晚期乳腺癌结局

2020-03-19

smlt2008 (审核中...)

前往app查看评论内容

#CAP#

Adv Healthc Mater：氧化石墨烯 - 铜纳米复合材料涂层多孔CaP支架通过激活Hif-1α进行血管化骨再生

2020-02-04

smlt2008 (审核中...)

前往app查看评论内容

#CAP#

2019 CAP指南：乳腺癌人表皮生长因子受体2免疫组化定量分析

2019-01-31

smlt2008 (审核中...)

前往app查看评论内容

#CAP#

J Gastroenterology：Glecaprevir联合Pibrentasvir治疗对既往直接抗病毒治疗失败的慢性丙型肝炎患者的实际疗效分析

2019-01-29

smlt2008 (审核中...)

前往app查看评论内容

#CAP#

ACS Appl Mater Interfaces：自组装可注射纳米复合水凝胶与原位生成的CaP纳米粒子协调骨再生

2019-08-30

smlt2008 (审核中...)

前往app查看评论内容

#CAP#

J Endod：一种全新根管内封药2-hydroxyisocaproic Acid的细胞毒性和基因毒性分析：一项体外研究

2019-10-24

smlt2008 (审核中...)

前往app查看评论内容

#CAP#

JCLA：CAPN10基因的SNP43 (G/A)多态性增加了脑小血管疾病认知障碍的风险？

2019-08-20

smlt2008 (审核中...)

前往app查看评论内容

#CAP#

JCO：Capmatinib联合Gefitinib治疗EGFR抑制失败的非小细胞肺癌患者

2018-09-18

smlt2008 (审核中...)

前往app查看评论内容

#CAP#

Medscape | 美国五大常见癌症治疗的第一医院有哪些？

2019-04-05

smlt2008 (审核中...)

前往app查看评论内容

#CAP#

2018 CAP临床实践指南：乳腺癌HER2检测

2019-03-08

科室
- - 订阅+
  - 更多科室
工具
服务